Short answer · Medically reviewed summary · Last updated: 2026-05-08
Juvenile Hyaline Fibromatosis is a rare genetic disorder caused by mutations in the CMG2 (also known as ANTXR2) gene, which provides instructions for making a protein essential for the proper turnover of the extracellular matrix. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease. What causes Juvenile Hyaline Fibromatosis? The primary cause of Juvenile Hyaline Fibromatosis is a dysfunction in the body’s ability to process and break down specific proteins in the connective tissue.
Which are the causes of Juvenile Hyaline Fibromatosis?
Causes of Juvenile Hyaline Fibromatosis explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
Juvenile Hyaline Fibromatosis is a rare genetic disorder caused by mutations in the CMG2 (also known as ANTXR2) gene, which provides instructions for making a protein essential for the proper turnover of the extracellular matrix. This condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to develop the disease.
What causes Juvenile Hyaline Fibromatosis?
The primary cause of Juvenile Hyaline Fibromatosis is a dysfunction in the body’s ability to process and break down specific proteins in the connective tissue. Think of the extracellular matrix as the "scaffolding" that holds your cells together; in this condition, the scaffolding becomes cluttered with an abnormal, rubbery material (hyaline). Because the CMG2 gene is faulty, the body cannot clear this material effectively, leading to the characteristic skin nodules and joint contractures associated with Juvenile Hyaline Fibromatosis.
Is Juvenile Hyaline Fibromatosis hereditary?
Yes, Juvenile Hyaline Fibromatosis is strictly a genetic condition. It is not caused by environmental triggers, infections, or autoimmune reactions. Because it follows an autosomal recessive inheritance pattern, parents of an affected child are typically asymptomatic carriers. When both parents carry one mutated copy of the gene, there is a 25% chance with each pregnancy that the child will inherit both mutated copies and develop Juvenile Hyaline Fibromatosis.
How do genetic mutations impact the body?
The CMG2 gene mutations disrupt cellular signaling pathways. Key impacts include:
- Protein Accumulation: Hyaline material builds up in the skin, joints, and sometimes internal organs.
- Defective Matrix Remodeling: Cells cannot properly signal the breakdown of old connective tissue.
- Vascular Involvement: The protein plays a role in capillary function, which may contribute to the severity of the lesions.
What is the current state of research?
While the genetic etiology of Juvenile Hyaline Fibromatosis is well-understood, researchers are currently focused on potential therapies that could stabilize the CMG2 protein or enhance its function. Current studies are investigating how to modulate the signaling pathways that lead to the buildup of hyaline, aiming to provide better management options for the 7 members of our Juvenile Hyaline Fibromatosis community and others worldwide.
Next steps
- Consult with a clinical geneticist to confirm the diagnosis through molecular genetic testing.
- Connect with the Juvenile Hyaline Fibromatosis community on DiseaseMaps.org to share experiences with others.
- Speak with a rheumatologist or dermatologist experienced in managing rare connective tissue disorders.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Juvenile Hyaline Fibromatosis
- Orphanet: Hyaline fibromatosis syndrome (ORPHA:340)
- Online Mendelian Inheritance in Man (OMIM): #228600
